Magnus Lindskog

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Docent i experimentell onkologi. Kliniskt verksam som läkare inom onkologi.
I mitt arbete kombinerar jag patientverksamhet på en onkologisk
universitetsklinik (Akademiska sjukhuset) med patientnära cancerforskning,
doktorandhandledning och undervisning av läkarstudenter.
Medlem av styrgruppen för den Nationella Forskarskolan för Klinisk
Cancerforskning (NatiOn), Svenska Njurcancergruppen, och Svenska
Palliativregistrets Forskargrupp.

Forskningsbeskrivning

Fokus ligger på (1) anti-angiogena och anti-inflammatoriska substansers
användbarhet i behandlingen av svårt sjuka cancerpatienter, främst
njurcancer och lungcancer
(2) Symtomkontroll hos cancerpatienter i livets
slutskede.

Artiklar

Article: JAMA NETWORK OPEN. 2023;6(3):e234149

Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial.

Werlenius K; Kinhult S; Solheim TS; Magelssen H; Löfgren D; Mudaisi M; Hylin S; Bartek J; Strandéus M; Lindskog M; Rashid HB; Carstam L; Gulati S; Solheim O; Bartek J; Salvesen Ø; Jakola AS
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;24(1):193

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature.

Tsakonas G; Koulouris A; Kazmierczak D; Botling J; Ortiz-Villalon C; Nord H; Lindskog M; Sandelin M; Micke P; Hydbring P; Ekman S
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(5-6):383-390

Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma.

Karlsson Rosenblad A; Sundqvist P; Harmenberg U; Hellström M; Hofmann F; Kjellman A; Kröger Dahlin B-I; Lindblad P; Lindskog M; Lundstam S; Ljungberg B
Article: BMC PALLIATIVE CARE. 2022;21(1):133

Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study.

Lindskog M; Schultz T; Strang P
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;40:38-45

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.

Lindskog M; Laurell A; Kjellman A; Melichar B; Rey PM; Zieliński H; Villacampa F; Bigot P; Zoltan B; Parikh O; Alba DV; Jellvert Å; Flaskó T; Gallardo E; Caparrós MJR; Purkalne G; Suenaert P; Karlsson-Parra A; Ljungberg B
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;39:22-28

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease-A National Register Study.

Almdalal T; Sundqvist P; Harmenberg U; Hellström M; Lindskog M; Lindblad P; Lundstam S; Ljungberg B
Article: ACTA NEUROCHIRURGICA. 2021;163(2):333-342

Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery.

Stenman M; Benmakhlouf H; Wersäll P; Johnstone P; Hatiboglu MA; Mayer-da-Silva J; Harmenberg U; Lindskog M; Sinclair G
Article: EUROPEAN JOURNAL OF CANCER. 2020;132:24-34

An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.

Tsakonas G; Lewensohn R; Botling J; Ortiz-Villalon C; Micke P; Friesland S; Nord H; Lindskog M; Sandelin M; Hydbring P; Ekman S
Article: ACTA ONCOLOGICA. 2019;58(4):432-438

Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative Care.

Elmstedt S; Mogensen H; Hallmans D-E; Tavelin B; Lundström S; Lindskog M
Article: ACTA ONCOLOGICA. 2019;58(3):306-312

Metastatic papillary renal cell carcinoma in the era of targeted therapy - a retrospective study from three European academic centres.

Stenman M; Staehler M; Szabados B; Sandström P; Laurell A; Lindskog M; Harmenberg U
Article: CANCER MANAGEMENT AND RESEARCH. 2019;11:1289-1297

Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis.

Redig J; Dalén J; Harmenberg U; Lindskog M; Ljungberg B; Lundstam S; Sandin R; Wahlgren T; Åkerborg Ö; Jakobsson M
Article: RADIOTHERAPY AND ONCOLOGY. 2018;127(3):501-506

Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014.

Stenman M; Sinclair G; Paavola P; Wersäll P; Harmenberg U; Lindskog M
Article: F1000RESEARCH. 2018;7:1797

Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial.

Jakola AS; Werlenius K; Mudaisi M; Hylin S; Kinhult S; Bartek J; Salvesen Ø; Carlsen SM; Strandéus M; Lindskog M; Löfgren D; Rydenhag B; Carstam L; Gulati S; Solheim O; Bartek J; Solheim T
Article: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2017;35(9):541.e15-541.e22

Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations.

Lindskog M; Wahlgren T; Sandin R; Kowalski J; Jakobsson M; Lundstam S; Ljungberg B; Harmenberg U
Article: BMC MEDICAL ETHICS. 2016;17(1):30

Heed or disregard a cancer patient's critical blogging? An experimental study of two different framing strategies.

Lynøe N; NattochDag S; Lindskog M; Juth N
Article: EUROPEAN JOURNAL OF CANCER. 2015;51(10):1331-1339

Old age as risk indicator for poor end-of-life care quality - a population-based study of cancer deaths from the Swedish Register of Palliative Care.

Lindskog M; Tavelin B; Lundström S
Article: MEDICAL ONCOLOGY. 2014;31(3):841

Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma.

Stenman M; Laurell A; Lindskog M
Article: BONE MARROW TRANSPLANTATION. 2013;48(6):843-848

Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion.

Al Hashmi S; Sadeghi B; Hassan Z; Abedi-Valugerdi M; Lindskog M; Hassan M
Article: EUROPEAN JOURNAL OF CANCER. 2013;49(1):115-120

Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy.

Sörenson S; Fohlin H; Lindgren A; Lindskog M; Bergman B; Sederholm C; Ek L; Lamberg K; Clinchy B
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(7):1703-1711

Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.

Gleissman H; Segerström L; Hamberg M; Ponthan F; Lindskog M; Johnsen JI; Kogner P
Article: LEUKEMIA & LYMPHOMA. 2010;51(11):2092-2097

Fish oil delays lymphoma progression in the TLL mouse.

Johansson A-S; Norén-Nyström U; Larefalk A; Holmberg D; Lindskog M
Article: FASEB JOURNAL. 2010;24(3):906-915

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.

Gleissman H; Yang R; Martinod K; Lindskog M; Serhan CN; Johnsen JI; Kogner P
Article: JOURNAL OF NATURAL PRODUCTS. 2009;72(11):1969-1974

Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs.

Felth J; Rickardson L; Rosén J; Wickström M; Fryknäs M; Lindskog M; Bohlin L; Gullbo J
Article: LEUKEMIA & LYMPHOMA. 2009;50(7):1198-1203

Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide.

Johansson A-S; Pawelzik S-C; Larefalk A; Jakobsson P-J; Holmberg D; Lindskog M
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(5):1227-1234

Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo.

Palmberg E; Johnsen JI; Paulsson J; Gleissman H; Wickström M; Edgren M; Ostman A; Kogner P; Lindskog M
Article: MOLECULAR CANCER THERAPEUTICS. 2007;6(9):2409-2417

The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo.

Wickström M; Johnsen JI; Ponthan F; Segerström L; Sveinbjörnsson B; Lindskog M; Lövborg H; Viktorsson K; Lewensohn R; Kogner P; Larsson R; Gullbo J
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(10):2584-2593

Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress.

Lindskog M; Gleissman H; Ponthan F; Castro J; Kogner P; Johnsen JI
Article: CANCER RESEARCH. 2004;64(20):7210-7215

Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.

Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2004;96(19):1457-1466

Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.

Lindskog M; Spenger C; Jarvet J; Gräslund A; Kogner P
Article: ONCOLOGY REPORTS. 2003;10(5):1587-1592

Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.

Ponthan F; Lindskog M; Karnehed N; Castro J; Kogner P
Article: BRITISH JOURNAL OF CANCER. 2003;88(3):478-485

Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS).

Lindskog M; Kogner P; Ponthan F; Schweinhardt P; Sandstedt B; Heiden T; Helms G; Spenger C
Article: CLINICAL CHEMISTRY. 2003;49(1):104-112

Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow.

Träger C; Kogner P; Lindskog M; Ponthan F; Kullman A; Kågedal B
Visa fler

Alla övriga publikationer

Other: SURGICAL NEUROLOGY INTERNATIONAL. 2020;11:21

Adaptive radiosurgery based on two simultaneous dose prescriptions in the management of large renal cell carcinoma brain metastases in critical areas: Towards customization.

Sinclair G; Stenman M; Benmakhlouf H; Johnstone P; Wersäll P; Lindskog M; Hatiboglu MA; Harmenberg U
Review: CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE. 2014;8(4):378-382

Glycaemic control in end-of-life care.

Lindskog M; Kärvestedt L; Fürst CJ
Review: CANCER LETTERS. 2005;228(1-2):195-201

NSAIDs in neuroblastoma therapy.

Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
Review: CANCER LETTERS. 2005;228(1-2):247-255

Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations.

Lindskog M; Spenger C; Klason T; Jarvet J; Gräslund A; Johnsen JI; Ponthan F; Douglas L; Nordell B; Kogner P
Published conference paper: SPECTROSCOPY. 2004;18(2):123-132

Monitoring intracellular metabolites in neuroblastoma with 1H NMR spectroscopy: effects of growth factor withdrawal and modulation of lipid metabolism

Lindskog M; Jarvet J; Graslund A; Kogner P

Anställningar

Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2022-2025

Examina och utbildning

Läkarexamen, Karolinska Institutet, 2006
MEDICINE DOKTORSEXAMEN, Institutionen för kvinnors och barns hälsa, Karolinska Institutet, 2004

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI